Composite Bone Scaffold for Soft Tissue Repair

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current tissue engineering scaffolds for soft tissue regeneration face challenges such as contraction, limited nutrient transport, and mechanical strength, with collagen hydrogels contracting significantly and PLGA foams degrading into acidic by-products that hinder tissue integration and regeneration.

Innovation Solution

A biocompatible scaffold made from demineralized cancellous bone is developed, with regions of crosslinked collagen for increased mechanical strength and resistance to degradation, and a porous structure to maintain shape and facilitate nutrient transport, incorporating hydrogels or extracellular matrix materials for enhanced integration and vascularization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If collagen hydrogels are used as scaffolds, then they provide biocompatibility and porous structure, but they contract significantly (up to 90%) which makes it difficult to promote integration with host tissue and generate necessary tissue mass

Engineering Contradiction:
Improvecontraction of scaffoldVSAvoidintegration with host tissue
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent combines collagen with synthetic polymers (PLA, PGA, or PLGA) to create a composite scaffold. The synthetic polymer component provides structural stability and resistance to contraction, while the collagen component maintains biocompatibility and promotes tissue integration. This composite approach resolves the contradiction by combining the advantages of both materials while mitigating their individual disadvantages.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent modifies the physical and chemical parameters of the scaffold by controlling the degree of crosslinking, porosity, and polymer composition. By adjusting these parameters, the scaffold maintains its shape and prevents excessive contraction while still allowing sufficient nutrient transport and tissue integration. The crosslinking density is optimized to balance structural integrity with tissue compatibility.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If collagen hydrogels are used as scaffolds, then they provide porous structure, but permeability decreases 100-1000 fold during contraction which limits ability to transport nutrients and waste products

Engineering Contradiction:
Improvedecrease in permeabilityVSAvoidtransport of nutrients and waste
Core Design Contradiction:
Object-affected harmful factorsVSQuantity of substance

Solution Approach 1:

The synthetic polymer component in the composite scaffold provides a stable porous framework that maintains permeability even when the collagen component contracts. This composite structure ensures continuous nutrient and waste transport pathways are preserved, resolving the contradiction between scaffold stability and nutrient transport capability.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The scaffold is designed with heterogeneous pore distribution and varying crosslinking densities in different regions. Areas with higher porosity are positioned where nutrient transport is most critical, while more densely crosslinked regions provide structural support. This local optimization ensures both structural integrity and adequate permeability throughout the scaffold.

Inventive Principle:
Principle #3Local quality

3Strength

If PLGA foams are used as scaffolds, then they provide structural support, but they degrade through autocatalytic process into acidic by-products that lower pH within tissue and often lead to cyst formation

Engineering Contradiction:
Improvemechanical strength of scaffoldVSAvoidacidic by-products from degradation
Core Design Contradiction:
StrengthVSObject-generated harmful factors

Solution Approach 1:

The patent introduces basic buffering agents (such as calcium carbonate, magnesium oxide, or ammonia) as intermediaries that neutralize the acidic by-products generated during PLGA degradation. These buffering agents act as a mediator between the degrading scaffold and the surrounding tissue, preventing pH drop and cyst formation while allowing the scaffold to maintain its mechanical strength throughout the degradation process.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The scaffold composition is optimized by adjusting the ratio of PLGA to buffering agents, controlling the degradation rate, and modifying the porosity to facilitate buffer distribution. These parameter changes ensure that the mechanical strength is maintained while the harmful acidic effects are minimized through controlled degradation and effective buffering.

Inventive Principle:
Principle #35Parameter changes

4Strength

If PLGA foams are used as scaffolds, then they provide structural framework, but they exhibit low mechanical strength relative to most tissues and surprisingly low permeability compared to structures with similar porosities

Engineering Contradiction:
Improvemechanical strength of scaffoldVSAvoidpermeability to nutrients
Core Design Contradiction:
StrengthVSQuantity of substance

Solution Approach 1:

The composite of collagen and PLGA/PGA/PLGA creates a synergistic structure where the collagen network provides additional load-bearing capacity and the synthetic polymer framework maintains porosity. This combination achieves both high mechanical strength and adequate permeability, resolving the contradiction that plagues pure PLGA foam scaffolds.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The scaffold allows for successful regeneration of soft tissues by promoting integration with host tissue, maintaining shape, and ensuring nutrient transport, addressing the limitations of existing scaffolds by providing mechanical integrity and vascularization.

Implementation Method 1

The region of demineralized bone may be stiffened by crosslinking or by physicochemically, including, but not limited to, by heating or stretching

Methodology Applied
Scientific EffectCrosslinking: Chemical Bonding

Implementation Method 2

as hydrogels contract, they exhibit a 100-1000 fold decrease in permeability which limits their ability to transport nutrients and waste products through the implant

Methodology Applied
Scientific EffectPermeability: Permeation

Implementation Method 3

processes that depend largely on the transport characteristics of the graft

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS9155607B2Compositions and methods for repair or regeneration of soft tissue
Publication Date: 2015.10.13 PURDUE RES FOUND
  • US9155607B2 patent drawing
  • US9155607B2 patent drawing
  • US9155607B2 patent drawing

AI summary

Disclosed are bioscaffolds and methods for use in soft tissue repair.